GPCR
Structure Therapeutics Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C+
Company Profile
CEO
Raymond C. Stevens
IPO Date
2023-02-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Structure Therapeutics Inc.
CEO
Raymond C. Stevens
IPO Date
2023-02-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 39,453 |
| $15.00 |
| 18 Jun 2026 | Waldstreicher Joanne | director | A-Award | Acquired | 39,453 | $15.00 |
| 18 Jun 2026 | DOBMEIER ERIC | director | A-Award | Acquired | 39,453 | $15.00 |
| 18 Jun 2026 | TETLOW SHARON | director | A-Award | Acquired | 39,453 | $15.00 |
| 18 Jun 2026 | WELCH DANIEL G | director | A-Award | Acquired | 39,453 | $15.00 |
| 23 Apr 2026 | Lang Matthew | COO & GC | A-Award | Acquired | 184,614 | $0.00 |
| 23 Apr 2026 | Lang Matthew | COO & GC | A-Award | Acquired | 223,776 | $18.08 |
| 23 Apr 2026 | Lang Matthew | — | Disposed | 0 | $0.00 |
| 16 Apr 2026 | FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | Disposed | 1,367 | $0.00 |